การประเมินโครงการและติดตามการใช้ยา Imipenem/Cilastatin ในโรงพยาบาลมหาราชนครราชสีมา* (Implementation of a Drug Use Evaluation (DUE) Program at Maharat Nakhon Ratchasima Hospital)
Article Sidebar
Main Article Content
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Fraser GL, Dickens JD, Wennberg DE, et al. Antibiotic optimization. Arch Intern Med 1997;157:1689-94.
American Society of Health-System Pharmacists. ASHP guidelines on medication-use evaluation. Am I Health-Syst Pharm 1996;53:1953-5.
Maswoswe IJ, Okpara AU. Enforcing a policy for restricting antimicrobial drug use. Am J Health-Syst Pharm 1995;52:1433-5
Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the infectious diseases society of America. J Infect Dis 1988; 157:869-76.
Suwangool P,Moola-or P,Waiwatana A, et al. Effect of a selection restriction policy on antibiotic expenditure and use: an institutional model. J Med Assoc Thai 1991:74:372-5.
Vimolsarawong N.Drugutlization evaluation of imipenem/cilastatin at Children's Hospital [M.Sc. Thesis in Phacy). Bangkok: Faculby of Graduate Studies, Mahidol University,1996.
Moline KA. Meeting JCAHO drug usage evaluation requirements in a small bospital. Hosp Pharm 1990;25:486-92.
Shelton PS, Hatton JT, Landsman PB, et al. Reliability of drug utilization evaluation as an assessment of medication appropriateness. Ann Pharmacother 1997;31:533-42.
Shlaes DM, Gerding DN, John JF, et al. Society for Healthcare Epidemiology of America and Infections Diseases Society of America. Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997;18:275-91.
John JF, Fishman NO.Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospial. Clin Infect Dis 1997;24:471-85.
Dron-Zeides,Raveh D,Schlesinger Y, Yinnon AM. Practical guidelines for vancomycin usage, with prospective drug-unlization evaluation. Infect Control Hosp Epidemiol 2000;21:45-7.
Hamiton CD, Drew R, Janning SW, Latour JK, Hayward S. Excessive use of vancomycin: a successful intervention strategy at an academic medical center. Infect Control Hosp Epidemiol 2000;21:42-5.
Quintiliani R, Cooper BW,Briceland LL, Nightingale CH. Econormic impact of streamlining antibiotic administration. Am J Med 1987;82:391-4.
Briceland LL, Lesar TS, Lomacstro BM, Lombardi TP, Gailey RA, Kowalsky SF. Streamlining antimicrobial therapy through pharmacists'review of of order sheet. Am J Hosp Pharm 1989;46:1376-80.
Murray MD,Kohler RB, McCarthy MC, Main JW.Attitudes of house staff physicians concerning various antibioticuse control programs. Am J Hosp Pharm 1988;45:584-8.
Echols RM, Kowalsky SF. The use of an antibiotic order form for antibiotic utization review: inffuence on physicians' prescnbing patterns. J Infect Dis 1984;1503-7.
Capens CC, Bess DT, Branam AC, et al. Antiotic surveillance: the results of a clinical pharmacy intervention program .Infect Control Hosp Epidemiol 1993:28:206-10,212.